Ben Tre Pharmaceutical Joint Stock Company

HOSE:DBT Stock Report

Market Cap: ₫244.3b

Ben Tre Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Pham Trieu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10.4yrs
CEO ownership19.7%
Management average tenureno data
Board average tenure2yrs

Recent management updates

Recent updates

CEO

Pham Trieu

10.4yrs

Tenure

Mr. Pham Thu Trieu is General Director of Ben Tre Pharmaceutical Joint Stock Company. Mr. Trieu had been Chairman at Ben Tre Pharmaceutical Joint Stock Company since December 5, 2014 and serves as its Dire...

Board Members

NamePositionTenureCompensationOwnership
Hanh Nguyen
Vice General Director & Chairman10.1yrsno data7.46%
₫ 18.2b
Pham Trieu
General Director & Director10.4yrsno data19.72%
₫ 48.2b
An Hoang
Vice General Director & Director1.1yrsno data1.49%
₫ 3.6b
Thi Hai Huynh
Member of the Supervisory Boardno datano datano data
Thien Nguyen
Member of the Supervisory Boardno datano datano data
Hoang Son Tran
Chief of Supervisory Boardno datano datano data
Tung Nguyen
Director2yrsno datano data
Duong Nguyen
HR Directorno datano datano data
Bao Nguyen Tran
Independent Director1.1yrsno datano data

2.0yrs

Average Tenure

Experienced Board: DBT's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 13:31
End of Day Share Price 2025/05/08 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ben Tre Pharmaceutical Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.